Michael Jeffers

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Nagma Khan, Michael Jeffers, Sampath Kumar et al. · Biochemical Journal · 2007 · 707 citations · Full text

Histone Modifications, Class Ii, Specific Isoforms +20

Activating mutations for the Met tyrosine kinase receptor in human cancer

Michael Jeffers, Laura S. Schmidt, Noboru Nakaigawa et al. · Proceedings of the National Academy of Sciences · 1997 · 440 citations

Tumor Biology, Radiation Oncology, Signal Transduction +14

PDGF-D, a new protease-activated growth factor

William J. LaRochelle, Michael Jeffers, William F. McDonald et al. · Nature Cell Biology · 2001 · 414 citations

Growth Hormone, Human Growth, Fibroblast Growth Factor +4

Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways

Guang‐Hui Xiao, Michael Jeffers, Alfonso Bellacosa et al. · Proceedings of the National Academy of Sciences · 2000 · 395 citations · Full text

Apoptosis, Immunology, Hgf/met Signaling +20

Met and hepatocyte growth factor/scatter factor expression in human gliomas.

Shahriar Koochekpour, Michael Jeffers, Shen Rulong et al. · PubMed · 1997 · 324 citations

Neuro-oncology, Tumoral Pathology, Tumor Innervation +15